CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments
China-based CF PharmTech, Inc., a specialist in inhalable drugs for respiratory diseases, has filed for...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity